Pomalidomide, Cyclophosphamide, and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Single-Center Experience — Ioannis Ntanasis‐Stathopoulos (2025) | RDL Network
Pomalidomide, Cyclophosphamide, and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Single-Center Experience
Article 2025 en
Authors
IN
Ioannis Ntanasis‐Stathopoulos
PM
Panagiotis Malandrakis
CF
Charalampos Filippatos
Abstract
1 min read
The addition of cyclophosphamide to Pd in moderately to heavily pretreated RRMM patients showed promising efficacy, supporting PCd as a potential therapeutic option in real-world clinical settings.
Sagar Lonial, Meletios A Dimopoulos, Jesús G. Berdeja, Paul G. Richardson, Hang Quach, Paula Rodríguez‐Otero, Paulo Maciag, Kevin Hong, Michael Amatangelo, Min Chen, Niels W.C.J. van de Donk
Rakesh Popat, Bradley Augustson, Paul Cannell, Keith Stockerl-Goldstein, Amit Khot, Ajay Nooka, N. Patel, Ravi S. Kasinathan, Astrid McKeown, Amy Curry, Mehreen Shaikh, Fernando Carreno, Sumita Roy-Ghanta, J. Opalinska, Hang Quach
Roman Hájek, Tamás Masszi, Maria Teresa Petrucci, Antonio Palumbo, Laura Rosiñol, Arnon Nagler, Kwee Yong, Albert Oriol, Jiří Minařík, Luděk Pour, Meletios A Dimopoulos, Vladimír Maisnar, Davide Rossi, H. Kasparu, Jan Van Droogenbroeck, Dina Ben Yehuda, Izhar Hardan, Matthew Jenner, Małgorzata Całbecka, M. Dávid, Javier de la Rubia, Johannes Drach,
Paul G. Richardson, Antonio Palumbo, Stephen Schey, Meletios A Dimopoulos, Thierry Façon, Katja Weisel, Peter O’Gorman, Xavier Leleu, Martha Q. Lacy, Matthew Streetly, Joseph Mıkhael, David S. Siegel, Jesús F. San Miguel, Kenneth C. Anderson
Shaji Kumar, Norbert Grząśko, Sosana Delimpasi, W Wiktor-Jędrzejczak, Sebastian Grosicki, Marie‐Christine Kyrtsonis, Andrew Spencer, Neeraj Gupta, Zhaoyang Teng, Catriona Byrne, Richard Labotka, Meletios A Dimopoulos
Discussion(0)
No comments yet. Be the first to comment.